While the Nobel-winning genome-editing technology CRISPR holds great promise, Duke’s Center for Advanced Genomic Technologies ...

July 30, 2024 — A research group has developed a new method that further improves the existing CRISPR/Cas technologies: it allows a more precise and seamless introduction of tags into proteins ...

CRISPR is a revolutionary tool that allows scientists to precisely modify the genome and gene expression of cells in any ...

Okomera announces Bpifrance funding to develop and standardize novel CRISPR screening assay to accelerate drug discovery in ...

CAMBRIDGE, Mass. and VANCOUVER, British Columbia and BASEL, Switzerland, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: ...

Engineers are facing more ethical dilemmas in their professional lives than ever before. Students need to be taught how to ...

CRISPR–Cas13 can rectify unusual splicing events. Demethylase is an enzyme that plays a crucial role in post-transcriptional modification (PTM), a process that occurs after transcription and ...

CRISPR Therapeutics recently proved it was capable of getting a drug approved. Next, its oncology and cardiovascular disease programs will need to show value. It may soon face some financial ...

The CRISPR–Cas13 system has wide clinical applications, such as diagnostics for RNA viruses, RNA imaging, RNA-base editing, RNA epigenome editing, and therapeutic interventions.

HuidaGene Therapeutics ("HuidaGene"), a global clinical-stage biotechnology company pioneering CRISPR-based programmable genome medicines, today announced the appointment of Dr. TJ Cradick as Chief ...